Concepedia

Laura Lunde

LL

12

Publications

1.6K

Citations

11

H-Index

2004

Active since

Affiliations

Dana-Farber Cancer Institute(Current)

Millennium Engineering and Integration (United States)

Massachusetts General Hospital

Saint Vincent Health System

University of Michigan

Laura Lunde is an author at Dana-Farber Cancer Institute specializing in pathology, transplantation, and urology.

Top concepts

Publications per year

2004–2015

12

Publications

12

Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma

Paul G. Richardson, Edie Weller, Sagar Lonial et al. · Blood · 2010 · 855 citations · Full text

A phase 2 trial of lenalidomide, bortezomib, and dexamethasone in patients with relapsed and relapsed/refractory myeloma

Paul G. Richardson, Wanling Xie, Sundar Jagannath et al. · Blood · 2014 · 183 citations · Full text

Multicenter, Phase I, Dose-Escalation Trial of Lenalidomide Plus Bortezomib for Relapsed and Relapsed/Refractory Multiple Myeloma

Paul G. Richardson, Edie Weller, Sundar Jagannath et al. · Journal of Clinical Oncology · 2009 · 162 citations

Hemorrhagic cystitis after allogeneic hematopoietic cell transplantation: risk factors, graft source and survival

Laura Lunde, Sandhyarani Dasaraju, Qing Cao et al. · Bone Marrow Transplantation · 2015 · 116 citations · Full text

, , +9

Lenalidomide Plus Bortezomib (Rev-Vel) in Relapsed and/or Refractory Multiple Myeloma (MM): Final Results of a Multicenter Phase 1 Trial.

Paul G. Richardson, Sundar Jagannath, David Avigan et al. · Blood · 2006 · 68 citations

Rows per page

1–5 of 12